{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T17:14:40Z","timestamp":1771607680489,"version":"3.50.1"},"reference-count":41,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"unspecified","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015226","name":"Shengjing Hospital of China Medical University","doi-asserted-by":"crossref","award":["M0323"],"award-info":[{"award-number":["M0323"]}],"id":[{"id":"10.13039\/501100015226","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,2,27]]},"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To analyse and explore the association between thyroid autoantibodies and diabetic kidney disease (DKD) in patients with type 2 diabetes mellitus (T2DM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A cross-sectional study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Patients were from the inpatient unit at The Second Endocrinology Department of Shengjing Hospital Affiliated to China Medical University (Shenyang, China) between January 2015 and September 2019.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>A total of 150 Chinese adults with T2DM were included in the study, including 83 men and 67\u2009women. Their age ranged between 25 and 92 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology<\/jats:title>\n                    <jats:p>They grouped by the presence of DKD, urine albumin-to-creatinine ratio (UACR), estimated glomerular filtration rate, and levels of thyroid peroxidase antibodies (TPOAb) and thyroglobulin antibodies (TgAb). Data on the patients\u2019 general characteristics and laboratory measurements (levels of fasting plasma glucose, glycated haemoglobin, and albumin; renal function; and thyroid function) were collected. Binary logistic regression was performed to identify risk factors for DKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The level of TPOAb, the positivity rates of TPOAb (p&lt;0.01) and TgAb (p&lt;0.05) were higher in patients with DKD than in those without DKD. The TPOAb level in patients with a UACR&lt;30\u2009mg\/g creatinine was lower than that in patients with a UACR between 30 and 300\u2009mg\/g creatinine (p&lt;0.05). The prevalence of DKD was higher in patients with a TPOAb-positive or TgAb-positive status. The result of binary logistic regression analysis showed that a TPOAb-positive status was significantly associated with DKD in patients with T2DM (OR=7.683, 95% CI 1.583 to 37.286, p&lt;0.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>TPOAb-positive status is in association with DKD in patients with T2DM. Large scale, prospective cohort studies are warranted to confirm our findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2023-077338","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:30:31Z","timestamp":1710808231000},"page":"e077338","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Association of thyroid autoantibodies and diabetic kidney disease in hospitalised patients with type 2 diabetes mellitus: a cross-sectional study from a Chinese university hospital"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7405-3872","authenticated-orcid":false,"given":"Zhi","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Shengjing Hospital of China Medical University, Shenyang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Futao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Changchun Center Hospital, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Shengjing Hospital of China Medical University, Shenyang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Shengjing Hospital of China Medical University, Shenyang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,3,18]]},"reference":[{"key":"2025121422334360000_14.3.e077338.1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.10924"},{"key":"2025121422334360000_14.3.e077338.2","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International diabetes Federation diabetes Atlas","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"2025121422334360000_14.3.e077338.3","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2017.10.011"},{"key":"2025121422334360000_14.3.e077338.4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/dmrr.2873","article-title":"Epidemiology of diabetic kidney disease in adult patients with type 1 diabetes in Italy: the AMD-annals initiative","volume":"33","author":"Pacilli","year":"2017","journal-title":"Diabetes Metab Res Rev"},{"key":"2025121422334360000_14.3.e077338.5","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-1246"},{"key":"2025121422334360000_14.3.e077338.6","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00030.2013"},{"key":"2025121422334360000_14.3.e077338.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2009.12.061"},{"key":"2025121422334360000_14.3.e077338.8","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.130249","article-title":"Alteration of thyroid hormone signaling triggers the diabetes-induced pathological growth, remodeling, and Dedifferentiation of Podocytes","volume":"4","author":"Benedetti","year":"2019","journal-title":"JCI Insight"},{"key":"2025121422334360000_14.3.e077338.9","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-10-0340"},{"key":"2025121422334360000_14.3.e077338.10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s40618-016-0560-3","article-title":"Subclinical hypothyroidism and diabetic nephropathy in Iranian patients with type 2 diabetes","volume":"40","author":"Mansournia","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"2025121422334360000_14.3.e077338.11","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1507\/endocrj.EJ14-0206","article-title":"Association between Subclinical hypothyroidism and diabetic nephropathy in patients with type 2 diabetes mellitus","volume":"61","author":"Furukawa","year":"2014","journal-title":"Endocr J"},{"key":"2025121422334360000_14.3.e077338.12","first-page":"S126","article-title":"Po157 thyroid dysfunction is associated diabetic nephropathy in patients with type 2 diabetes","volume":"106","author":"Kim","year":"2014","journal-title":"Diab\u00a0Res Clin Pract"},{"key":"2025121422334360000_14.3.e077338.13","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2019.00440","article-title":"Risk factors of thyroid dysfunction in patients with type 2 diabetes mellitus","volume":"10","author":"Ogbonna","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025121422334360000_14.3.e077338.14","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.4103\/jfmpc.jfmpc_838_20","article-title":"Thyroid dysfunction in patients with type 2 diabetes mellitus and its association with diabetic complications","volume":"9","author":"Mehalingam","year":"2020","journal-title":"J Family Med Prim Care"},{"key":"2025121422334360000_14.3.e077338.15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2007.02270.x"},{"key":"2025121422334360000_14.3.e077338.16","first-page":"1583","article-title":"Thyroid function in type 2 diabetes mellitus and in diabetic nephropathy","volume":"7","year":"2013","journal-title":"JCDR"},{"key":"2025121422334360000_14.3.e077338.17","doi-asserted-by":"crossref","DOI":"10.1186\/s12902-020-00650-0","article-title":"The association between albuminuria and thyroid antibodies in newly diagnosed type 2 diabetes mellitus patients with Hashimoto\u2019s thyroiditis and Euthyroidism","volume":"20","author":"Zhu","year":"2020","journal-title":"BMC Endocr Disord"},{"key":"2025121422334360000_14.3.e077338.18","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4798947","article-title":"Thyroid parameters and kidney disorder in type 2 diabetes: results from the METAL study","volume":"2020","author":"Chen","year":"2020","journal-title":"J Diabetes Res"},{"key":"2025121422334360000_14.3.e077338.19","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1515\/biol-2021-0064","article-title":"Is there a relationship between the prevalence of autoimmune thyroid disease and diabetic kidney disease","volume":"16","author":"Stefanowicz-Rutkowska","year":"2021","journal-title":"Open Life Sci"},{"key":"2025121422334360000_14.3.e077338.20","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S"},{"key":"2025121422334360000_14.3.e077338.21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1114248"},{"key":"2025121422334360000_14.3.e077338.22","doi-asserted-by":"crossref","DOI":"10.11604\/pamj.2018.29.137.12992","article-title":"Thyroid hormone status in Ghanaian patients with chronic kidney disease","volume":"29","author":"Aryee","year":"2018","journal-title":"Pan Afr Med J"},{"key":"2025121422334360000_14.3.e077338.23","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s12020-018-1582-8","article-title":"Higher free Triiodothyronine concentration is associated with lower prevalence of microangiopathic complications and better metabolic control in adult euthyroid people with type 1 diabetes","volume":"60","author":"Falkowski","year":"2018","journal-title":"Endocrine"},{"key":"2025121422334360000_14.3.e077338.24","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2012.0475"},{"key":"2025121422334360000_14.3.e077338.25","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2008070730"},{"key":"2025121422334360000_14.3.e077338.26","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-1098"},{"key":"2025121422334360000_14.3.e077338.27","doi-asserted-by":"crossref","first-page":"795","DOI":"10.4103\/2230-8210.192893","article-title":"Prevalence of hypothyroidism in diabetic kidney disease and effect of thyroid hormone replacement on estimate glomerular filtration rate","volume":"20","author":"Bajaj","year":"2016","journal-title":"Indian J Endocrinol Metab"},{"key":"2025121422334360000_14.3.e077338.28","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4103\/ijem.IJEM_572_17","article-title":"Thyroid status in patients with type 2 diabetes attending a tertiary care hospital in Eastern India","volume":"22","author":"Pramanik","year":"2018","journal-title":"Indian J Endocrinol Metab"},{"key":"2025121422334360000_14.3.e077338.29","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2009.304"},{"key":"2025121422334360000_14.3.e077338.30","doi-asserted-by":"crossref","DOI":"10.5812\/ijem.103750","article-title":"Prevalence of Subclinical hypothyroidism in chronic kidney disease in a population-based study: Tehran thyroid study","volume":"19","author":"Kazempour-Ardebili","year":"2021","journal-title":"Int J Endocrinol Metab"},{"key":"2025121422334360000_14.3.e077338.31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/hdi.12339","article-title":"High prevalence of Subclinical hypothyroidism and nodular thyroid disease in patients on Hemodialysis","volume":"20","author":"Da Costa","year":"2016","journal-title":"Hemodial Int"},{"key":"2025121422334360000_14.3.e077338.32","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1159\/000512968","article-title":"Hemodilution impacts assessment of thyroid status before and after Hemodialysis in patients with end-stage renal disease","volume":"51","author":"Sanai","year":"2021","journal-title":"Am J Nephrol"},{"key":"2025121422334360000_14.3.e077338.33","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/thy.2019.0167","article-title":"Hypothyroidism and kidney function: A Mendelian randomization study","volume":"30","author":"Ellervik","year":"2020","journal-title":"Thyroid"},{"key":"2025121422334360000_14.3.e077338.34","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0090-1229(76)90087-8","article-title":"Thyroid antigen-antibody nephritis","volume":"6","author":"O\u2019Regan","year":"1976","journal-title":"Clin Immunol Immunopathol"},{"key":"2025121422334360000_14.3.e077338.35","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-08-0837"},{"key":"2025121422334360000_14.3.e077338.36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2006.02531.x"},{"key":"2025121422334360000_14.3.e077338.37","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-008-0973-0"},{"key":"2025121422334360000_14.3.e077338.38","doi-asserted-by":"crossref","first-page":"8797","DOI":"10.1002\/jcp.27539","article-title":"Ea15, Mir22, Linc00472 as diagnostic markers for diabetic kidney disease","volume":"234","author":"Wang","year":"2019","journal-title":"J Cell Physiol"},{"key":"2025121422334360000_14.3.e077338.39","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/eci.12404","article-title":"GADA and anti-Znt8 complicate the outcome of Phenotypic type 2 diabetes of adults","volume":"45","author":"Haller-Kikkatalo","year":"2015","journal-title":"Eur J Clin Invest"},{"key":"2025121422334360000_14.3.e077338.40","doi-asserted-by":"crossref","DOI":"10.1186\/s13098-015-0093-5","article-title":"Endothelin-1 gene Polymorphisms and diabetic kidney disease in patients with type 2 diabetes mellitus","volume":"7","author":"Zanatta","year":"2015","journal-title":"Diabetol Metab Syndr"},{"key":"2025121422334360000_14.3.e077338.41","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.intimp.2013.11.017","article-title":"Polymorphisms of Endothelin 1 (G5665t and T-1370G) and Endothelin receptor type A (C+70G and G-231A) in graves' disease","volume":"18","author":"Ayd\u0131n","year":"2014","journal-title":"Int Immunopharmacol"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-077338","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:33:56Z","timestamp":1765780436000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-077338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3,18]]},"published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1136\/bmjopen-2023-077338"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-077338","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3]]}}}